Atlas Trials

Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC)

Clinical trial NCT02432846 · COMPLETED

Trial details

NCT number
NCT02432846
Sponsor
Mendus
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Renal Cell Carcinoma, Metastatic
Start date
2015-04-01
Primary completion
2021-01-31
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.